ST-elevation myocardial infarction
ICD-10 I21 · ICD-11 BA41.0

Treatment of ST-elevation myocardial infarction with ischaemic symptom duration of 12 hours or less when primary PCI is achievable within 120 minutes

Clinical scenario

This protocol addresses patients with a working diagnosis of ST-elevation myocardial infarction — characterised by persistent ST-segment elevation or equivalent ECG findings — in whom ischaemic symptoms have been present for 12 hours or less and where the anticipated time from diagnosis to primary percutaneous coronary intervention is under 120 minutes.

Reperfusion goals

The clinical aim is successful reperfusion: at least 50% ST-segment resolution on ECG, resolution of ischaemic symptoms, and haemodynamic stability.

Approach (partial overview)

In this time-sensitive scenario, the guideline-recommended strategy centres on primary percutaneous coronary intervention as the preferred method of restoring coronary blood flow, combined with antithrombotic therapy. The complete regimen — covering specific agents, sequencing, supportive measures, and contingency options — is defined in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehad191

  1. Reperfusion therapy is recommended in all patients with a working diagnosis of STEMI (persistent ST-segment elevation or equivalents) and symptoms of ischaemia of ≤12 h duration.
  2. A PPCI strategy is recommended over fibrinolysis if the anticipated time from diagnosis to PCI is <120 min.
  3. In patients with a working diagnosis of STEMI, a PPCI strategy (i.e. immediate angiography and PCI as needed) is the preferred reperfusion strategy, provided it can be performed in a timely manner (i.e. within 120 min of the ECG-based diagnosis).
  4. Successful reperfusion is generally associated with significant improvement in ischaemic symptoms, ≥50% ST-segment resolution, and haemodynamic stability.
View source ↗